loading page

Transcatheter „valve-in-valve“ mitral valve replacement for patient-prosthesis mismatch: Chronicle of a death foretold
  • +1
  • Mateo Marin-Cuartas,
  • Thilo Noack,
  • Philipp Kiefer,
  • Michael Borger
Mateo Marin-Cuartas
Herzzentrum Leipzig Universitatsklinik
Author Profile
Thilo Noack
Herzzentrum Leipzig Universitatsklinik
Author Profile
Philipp Kiefer
Herzzentrum Leipzig Universitatsklinik
Author Profile
Michael Borger
Herzzentrum Leipzig Universitatsklinik
Author Profile

Abstract

Severe mitral annular calcification (MAC) may represent a challenging issue which can lead to poor outcomes and serious issues such as patient-prosthesis mismatch (PPM). The potential harmful effect of PPM must be prevented through the use of alternative techniques that allow mitral valve replacement with adequately sized bioprostheses in patients with MAC. PPM should be recognized as a contraindication for transcatheter valve-in-valve replacement as it leads to poor outcomes and early prosthetic degeneration.

Peer review status:ACCEPTED

19 Aug 2020Submitted to Journal of Cardiac Surgery
20 Aug 2020Submission Checks Completed
20 Aug 2020Assigned to Editor
24 Aug 2020Reviewer(s) Assigned
04 Sep 2020Review(s) Completed, Editorial Evaluation Pending
05 Sep 2020Editorial Decision: Revise Minor
07 Sep 20201st Revision Received
08 Sep 2020Submission Checks Completed
08 Sep 2020Assigned to Editor
09 Sep 2020Review(s) Completed, Editorial Evaluation Pending
09 Sep 2020Editorial Decision: Accept